Whether you live with bipolar disorder or major depressive disorder, you experience periods of depression. This can make it hard to tell them apart. But the bi-in bipolar means “two” because it has ...

The FDA approved lumateperone (Caplyta) for bipolar-related depressive episodes, Intra-Cellular Therapies announced Monday. The atypical antipsychotic gained an indication for the treatment of ...

Dr. Harold Koenig answers the question: 'What Is Depression?' — -- Question: What is the difference between depression and manic depression (bipolar disorder)? Answer: Depression and manic ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...

Dr. Roy Perlis answers the question: 'Bipolar Disorder & 'Regular' Depression?' — -- Question: How is bipolar disorder different from unipolar depression or 'regular' depression? Answer: Both ...

Treatment with modern antidepressants may help prevent patients with bipolar disorder from relapsing into a depressive episode, according to an international clinical trial led by researchers at the ...

Synthetic psilocybin with psychotherapy was effective and safe for patients with treatment-resistant bipolar depression, a small nonrandomized controlled trial suggested. Among 15 people with bipolar ...

One dose of synthetic psilocybin in combination with psychotherapy significantly reduces treatment-resistant depression associated with bipolar II disorder (BDII), a small, nonrandomized clinical ...